CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-10 | PAPA JOSEPH C Director | Option exercise · Restricted Share Units | −116,697 | $9.40 | $1.1M | 0 |
| 2022-05-10 | PAPA JOSEPH C Director | Grant or award · Restricted Share Units | +183,522 | 0 | ||
| 2022-05-10 | PAPA JOSEPH C Director | Option exercise · Restricted Share Units | −183,522 | $9.40 | $1.7M | 0 |
| 2022-05-10 | PAPA JOSEPH C Director | Grant or award · Restricted Share Units | +65,911 | 0 | ||
| 2022-05-10 | PAPA JOSEPH C Director | Option exercise · Restricted Share Units | −65,911 | $9.40 | $620K | 0 |
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Option exercise | +8,643 | 99,149 | ||
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Option exercise | +13,592 | 112,741 | ||
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Grant or award · Restricted Share Units | +8,643 | 0 | ||
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Option exercise · Restricted Share Units | −8,643 | $9.40 | $81K | 0 |
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Grant or award · Restricted Share Units | +13,592 | 0 | ||
| 2022-05-10 | Spurr Robert President, U.S. Businesses | Option exercise · Restricted Share Units | −13,592 | $9.40 | $128K | 0 |
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise | +12,447 | 487,714 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise | +19,575 | 507,289 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Grant or award · Restricted Share Units | +12,447 | 0 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise · Restricted Share Units | −12,447 | $9.40 | $117K | 0 |
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Grant or award · Restricted Share Units | +19,575 | 0 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise · Restricted Share Units | −19,575 | $9.40 | $184K | 0 |
| 2022-05-03 | Munsch Frederick SVP, Controller and CAO | Shares withheld for taxes | −747 | $18.66 | $14K | 22,435 |
| 2022-04-14 | Spurr Robert U.S. President-Pharma Business | Sale | −1,595 | $22.19 | $35K | 90,506 |
| 2022-03-31 | WECHSLER AMY B Director | Grant or award | +300 | $22.85 | $7K | 99,354 |
Page 14 of 23 · 453 trades